alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Charles Kean FULTON, Appellant, v. CERTAIN UNDERWRITERS AT LLOYD'S LONDON SUBSCRIBING TO POLICY NUMBERS B0621MMILSYC10025 AND B0621MMILYPI10306, Oversea Insurance Agency, Inc., Miller Insurance Services, LLP, and Thames Insurance Services, Inc., Appellees.

No. 4D17-981

District Court of Appeal of Florida, Fourth District.

[April 12, 2018]

David W. Rodstein of Rodstein Law, P.A., Tamarac, for appellant.

Darlene M. Lidondici and Christopher R. Fertig of Fertig & Gramling, Fort Lauderdale, for appellee Oversea Insurance Agency Inc.

Armando P. Rubio of Fields Howell, LLP, Miami, for appellees Underwriters and Miller Insurance Services, LLP.

Shawn R. Horwick of Ritter Chusid, LLP, Coral Springs, for appellee Thames Insurance Services, Inc.

Per Curiam.

*Affirmed.*

Warner, Gross and Levine, JJ., concur.
Jimmy Lee WHEELER, Appellant/Petitioner(s), v. STATE of Florida, Appellee/Respondent(s).

CASE NO.: 2D17-4914

District Court of Appeal of Florida, Second District.

February 08, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Certiorari is dismissed.
Calvin EATON, Appellant, v. STATE of Florida, Appellee.

Case No. 5D17-3681

District Court of Appeal of Florida, Fifth District.

January 2, 2018

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
<PAGE>

Exhibit 99.15

Contact:          Jerry B. Hook, Ph.D.
                  President & Chief Executive Officer
                  Sparta Pharmaceuticals, Inc.
                  (215) 442-1700, Ext. 205

FOR IMMEDIATE RELEASE

 Sparta Pharmaceuticals, Inc. Announces Patent Approval From The United States
                          Patent and Trademark Office

         Horsham, PA, July 1, 1997, Sparta Pharmaceuticals, Inc. (NASDAQ: SPTA,
SPTAU, SPTAW, SPTAZ AND SPTAL) announced that the United States Patent and
Trademark Office has granted United States Patent #5,637,479 submitted by Dr.
Harvey Rubin and colleagues of The University of Pennsylvania (Penn). The patent
is entitled, "A Method of Modulating DNA Binding Activity of Recombinant alpha
-1-Antichymotrypsin And Other Serine Protease Inhibitors". This is the sixth
United States patent to be granted through Sparta's collaboration with Penn.

Through a Sparta funded grant, Dr. Rubin, who is a scientific advisor to The
Company, has created a new class of recombinant modified human proteins that are
specific serine protease inhibitors. The Company has an exclusive license to
over sixty compounds covered in the six U.S. patents issued to Penn;
international patents are pending.

According to Dr. Jerry B. Hook, Sparta's President and Chief Executive Officer,
"The issuance of this patent will further enhance Sparta's strong proprietary
position regarding recombinant serine protease inhibitors, their production and
use."

The Company believes this recombinant serine protease inhibitor program has the
potential to be successful in treating serious conditions where uncontrolled
inflammatory responses may have fatal consequences including: cardiovascular
disorders, stroke, lung inflammation and pancreatitis.

This press release contains certain forward-looking statements within the
meaning of the "safe harbor" provisions of the Private Securities Litigation
Reform Act of 1995. Such statements are made based on management's current
expectations and beliefs, and actual results may vary from those currently
anticipated based upon a number of factors, including uncertainties inherent in
the drug development process, including clinical trials. The Company undertakes
no obligation to release publicly any revisions which may be made to reflect
events or circumstances after the date hereof.


<PAGE>







Sparta is a development stage pharmaceutical company engaged in the business of
acquiring rights to, and developing for commercialization, technologies and
drugs for the treatment of a number of life threatening diseases including
cancer, cardiovascular disorders and inflammation. The Company has focused on
acquiring compounds that have been previously tested in humans and animals and
technologies that may improve the delivery or targeting of previously tested,
and in some cases marketed, anticancer agents. Sparta's foundation in cancer
chemotherapy has been augmented by the addition of new technology in the rapidly
expanding field of serine protease inhibitors. Serine protease inhibitors have
wide applications in diverse fields such as inflammation, reperfusion injury and
stroke.
**UN PUBLISHED** 
UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

**No. 16**  **- 1260** 

ADRIAN D. PUGH , Plaintiff

– Appellant ,

v.
MONTGOMERY COUNTY BOARD OF EDUCATION , Defendant

– Appellee , and EQUAL EMPLOYMENT OPPORTUNITY COMMISSION , Defendant

.

Appeal from the United States District Court for the District of Maryland , at Greenbelt

. Deborah K. Chasanow, Senior District Judge. ( 8:13

- cv - 02862

- DKC )

Submitted : July 21, 2016 Decided: July 25, 2016

Before SHEDD, AGEE , and WYNN , Circuit Judges.

Affirmed by un published per curiam opinion

.
Adrian D. Pugh, Appellant Pro Se. Edward B. Lattner, COUNTY ATTORNEY’S OFFICE, Rockville, Maryland, for Appellee.

Unpublished opinions are not binding precedent in this circuit.2 PER CURIAM: Adrian D. Pugh appeals the district court’s judgment granting the Montgomery County Board of Education’s summary judgment motion on her race discrimination claim s , brought pursuant to Title VII of the Civil Rights Act of 1964, as amended, 42 U.S.C. A. §§ 2000e to 2000e

- 17 ( West 2012 & Supp.
2015 ). We have reviewed the record and find no reversible error. Accordingly, although we grant Pugh’s application to proceed in forma pauperis, we affirm for the r easons stated by
the district court. See Pugh v. Montgomery Cty. Bd. o f Educ. , No. 8:13

- cv - 02862

- DKC (D. Md

. Feb. 12, 2016 ). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before this cour t and argument would not aid the decisional process.

AFFIRMED
<TABLE> <S> <C>


<ARTICLE> 5

<S>                                  <C>
<PERIOD-TYPE>                        3-MOS
<FISCAL-YEAR-END>                             JUN-30-2000
<PERIOD-START>                                JAN-01-2000
<PERIOD-END>                                  MAR-31-2000
<CASH>                                            533,000
<SECURITIES>                                            0
<RECEIVABLES>                                  45,662,000
<ALLOWANCES>                                    2,012,000
<INVENTORY>                                     6,735,000
<CURRENT-ASSETS>                               54,778,000
<PP&E>                                         14,674,000
<DEPRECIATION>                                  7,781,000
<TOTAL-ASSETS>                                 82,836,000
<CURRENT-LIABILITIES>                          15,441,000
<BONDS>                                                 0
<PREFERRED-MANDATORY>                                   0
<PREFERRED>                                             0
<COMMON>                                          121,000
<OTHER-SE>                                     67,274,000
<TOTAL-LIABILITY-AND-EQUITY>                   82,836,000
<SALES>                                        57,596,000
<TOTAL-REVENUES>                               57,596,000
<CGS>                                          47,463,000
<TOTAL-COSTS>                                  61,694,000
<OTHER-EXPENSES>                                        0
<LOSS-PROVISION>                                  608,000
<INTEREST-EXPENSE>                                 43,000
<INCOME-PRETAX>                                (4,141,000)
<INCOME-TAX>                                   (1,615,000)
<INCOME-CONTINUING>                            (2,526,000)
<DISCONTINUED>                                    635,000
<EXTRAORDINARY>                                         0
<CHANGES>                                               0
<NET-INCOME>                                   (1,891,000)
<EPS-BASIC>                                         (0.16)
<EPS-DILUTED>                                       (0.16)



</TABLE>
#### In the Matter of Anthony Bonacci, Petitioner, v Glenn S. Goord, as Commissioner of Correctional Services, Respondent.

[769 NYS2d 912]

Proceeding pursuant to CPLR article 78 (transferred to this Court by order of the Supreme Court, entered in Franklin County) to review a determination of respondent which found petitioner guilty of violating a prison disciplinary rule.

Petitioner was found guilty of violating the prison disciplinary rule prohibiting fighting after he and his cellmate engaged in a physical altercation that left both of them injured. Substantial evidence supports the determination of petitioner’s guilt in the form of the misbehavior report, the hearing testimony given by two correction officers and a facility nurse, and by petitioner’s own testimony in which he conceded that he had participated in the fight *(see Matter of Ortiz v Goord,*298 AD2d 736 [2002]; *Matter of Carter v Goord,*266 AD2d 623, 624 [1999]). Petitioner’s contention that his cellmate was the aggressor and that he became involved in the fight solely to defend himself raised an issue of credibility for resolution by the Hearing Officer *(see Matter of Ortiz v Goord, supra*at 737; *Matter of Gloster v Goord,*278 AD2d 568 [2000], *appeal dismissed*96 NY2d 825 [2001]).

We are not persuaded by petitioner’s assertion that procedural errors and omissions deprived him of the right to a fair hearing. For example, the misbehavior report was not invalid because it was not written by an eyewitness to the charged misconduct. As no staff member observed the fight, the report was appropriately prepared by a correction officer based upon her subsequent investigation into the incident *(see*7 NYCRR 251-3.1 [b]; *see also Matter of Hernandez v Selsky,*308 AD2d 671 [2003]). The remaining arguments raised by petitioner have been examined and found to be without merit.

Mercure, J.P., Spain, Carpinello, Mugglin and Kane, JJ., concur. Adjudged that the determination is confirmed, without costs, and petition dismissed.
Clay E. BOYER, III, Appellant, v. STATE of Florida, Appellee.

No. 4D18-540

District Court of Appeal of Florida, Fourth District.

April 12, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

JUDGMENT RENDERED NOVEMBER 21, 2019

NO. 03-19-00003-CV

Appellants, T. Mark Anderson and Christine Anderson, Co-Executors of the Estate of 

Ted Anderson// Cross-Appellants, David B. Archer, Carol Archer Bugg, John V. Archer, 

Karen Archer Ball, and Sherri Archer

v.

Appellees, David B. Archer, Carol Archer Bugg, John V. Archer, Karen Archer Ball, and 

Sherri Archer// Cross-Appellees, T. Mark Anderson and Christine Anderson, 

Co-Executors of the Estate of Ted Anderson

APPEAL FROM THE 345TH DISTRICT COURT OF TRAVIS COUNTY

BEFORE CHIEF JUSTICE ROSE, JUSTICES KELLY AND SMITH

AFFIRMED -- OPINION BY JUSTICE SMITH

This is an appeal from the order signed by the trial court on December 20, 2018. Having 

reviewed the record and the parties’ arguments, the Court holds that there was no reversible 

error in the trial court’s order. Therefore, the Court affirms the trial court’s order. Each party 

shall bear their own costs relating to this appeal, both in this Court and in the court below.
STATE of Louisiana v. Derrick GUMMS

No. 2017-KO-2152

Supreme Court of Louisiana.

June 1, 2018

**ON WRIT OF CERTIORARI TO THE COURT OF APPEAL, FIFTH CIRCUIT, PARISH OF JEFFERSON**

Writ denied.

Hughes, J., would grant the writ in order to ascertain the correct date.
Kenneth Eric STEWART v. Edvatte Rena STEWART

2160175

Court of Civil Appeals of Alabama.

January 12, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Dismissed.
Spencer PEEPLES, Appellant/Petitioner(s), v. STATE of Florida, Appellee/Respondent(s).

CASE NO.: 2D18-1348

District Court of Appeal of Florida, Second District.

May 17, 2018

BY ORDER OF THE COURT:

The petition for belated appeal of the summary denial of petitioner's postconviction motion in the trial court is granted in circuit court case number CRC08-18029-CFANO for review of the trial court's order of February 7, 2018.

The circuit court clerk shall treat this order as a notice of appeal, promptly certify same and return it to this court as with any notice of appeal, and a new appellate case number will be assigned to this appeal and an acknowledgment letter will issue at that time. The summary record shall be transmitted to this court when the certified copy of this order is returned by the trial court clerk.

After a new appellate case number is assigned and an acknowledgment letter has issued, this court will issue an order advising the appellant of the due date of the optional initial brief.

BLACK, SALARIO, and ROTHSTEIN-YOUAKIM, JJ., Concur.
EXHIBIT
32.1
 
 CERTIFICATION
OF CHIEF EXECUTIVE OFFICER
 
 PURSUANT
TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO
 SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
 
 The
undersigned, Gerald E. Bisbee, Jr. the Chief Executive Officer of ReGen
Biologics, Inc. (the “Company”), has executed this certification in connection
with the filing with the Securities and Exchange Commission of the Company’s
Quarterly Report on Form 10-Q for the quarterly period ending September 30, 2008
(the “Report”). The undersigned hereby certifies that:
 
 (1) the
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended; and
 
 (2) the
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
 
 Date:
November 10, 2008
 
 /s/
      GERALD E. BISBEE, JR.Name:
                  Gerald E. Bisbee,
      Jr.Title:
                  President
      and Chief Executive Officer
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 6009 Referred in Senate (RFS)]

<DOC>
118th CONGRESS
  2d Session
                                H. R. 6009

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             March 21, 2024

   Received; read twice and referred to the Committee on Energy and 
                           Natural Resources

_______________________________________________________________________

                                 AN ACT

 
 To require the Director of the Bureau of Land Management to withdraw 
the proposed rule relating to fluid mineral leases and leasing process, 
                        and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Restoring American Energy Dominance 
Act''.

SEC. 2. WITHDRAWAL OF BLM PROPOSED RULE.

    (a) In General.--Not later than 30 days after the date of enactment 
of this Act, the Director of the Bureau of Land Management shall 
withdraw the proposed rule of the Bureau of Land Management entitled 
``Fluid Mineral Leases and Leasing Process'' (88 Fed. Reg. 47562 (July 
24, 2023)).
    (b) No Further Action.--The Director of the Bureau of Land 
Management may not take any action to finalize, implement, or enforce 
the proposed rule described in subsection (a) or any substantially 
similar rule.

            Passed the House of Representatives March 20, 2024.

            Attest:

                                             KEVIN F. MCCUMBER,

                                                                 Clerk.
```
Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

The certification set forth below is being submitted in
connection with the Quarterly Report of First Data Corporation on Form 10-Q for the period ended June 30, 2009 (the Report) for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934
(the Exchange Act) and Section 1350 of Chapter 63 of Title 18 of the United States Code.

Michael D. Capellas, the Chief
Executive Officer of First Data Corporation, certifies that, to the best of his knowledge:



|1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and
|-- | --------------------------------------------------------------------------------------------------



|2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of First Data Corporation.
|-- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------



|                      |  |  |  |                           
|--------------------- |  |  |  | --------------------------
|Date: August 14, 2009 |  |  |  | /s/    Michael D. Capellas
|                      |  |  |  | Michael D. Capellas       
|                      |  |  |  | Chief Executive Officer
Exhibit 99.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Glacier Water Services, Inc., (the Company) on Form 10-Q for the period ended March 30,
2003 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, W. David Walters, Senior Vice President and Chief Financial Officer of the Company, certify, pursuant to and for purposes of 18 U.S.C. § 1350, as
adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

| | (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and                                                                                                  
| | --- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition of the Company as of the dates indicated and results of operations of
the Company for the periods indicated.

|/s/ W. DAVID WALTERS                                                           | 
|------------------------------------------------------------------------------ | 
|                                                                               | 
|W. David Walters Senior Vice President and Chief Financial Officer May 3, 2003 |
```

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1395 Engrossed in House (EH)]

<DOC>
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
117th CONGRESS
  1st Session
                                H. R. 1395

_______________________________________________________________________

                                 AN ACT

 
 To require the Secretary of Housing and Urban Development to discount 
 FHA single-family mortgage insurance premium payments for first-time 
    homebuyers who complete a financial literacy housing counseling 
                                program.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Housing Financial Literacy Act of 
2021''.

SEC. 2. DISCOUNT ON MORTGAGE INSURANCE PREMIUM PAYMENTS FOR FIRST-TIME 
              HOMEBUYERS WHO COMPLETE FINANCIAL LITERACY HOUSING 
              COUNSELING PROGRAMS.

    The second sentence of subparagraph (A) of section 203(c)(2) of the 
National Housing Act (12 U.S.C. 1709(c)(2)(A)) is amended--
            (1) by inserting before the comma the following: ``and such 
        program is completed before the mortgagor has signed an 
        application for a mortgage to be insured under this title or a 
        sales agreement''; and
            (2) by striking ``not exceed 2.75 percent of the amount of 
        the original insured principal obligation of the mortgage'' and 
        inserting ``be 25 basis points lower than the premium payment 
        amount established by the Secretary under the first sentence of 
        this subparagraph''.

            Passed the House of Representatives April 20, 2021.

            Attest:

                                                                 Clerk.
117th CONGRESS

  1st Session

                               H. R. 1395

_______________________________________________________________________

                                 AN ACT

 To require the Secretary of Housing and Urban Development to discount 
 FHA single-family mortgage insurance premium payments for first-time 
    homebuyers who complete a financial literacy housing counseling 
                                program.
```
#### CONG THANH CHAU, Petitioner, v. Jefferson B. SESSIONS III, Attorney General, Respondent.

No. 16-70010

United States Court of Appeals, Ninth Circuit.

Submitted March 8, 2017 *

Filed March 16, 2017

Cong Thanh Chau, Pro Se

Rachel Louise Browning, Trial Attorney, Edward C. Durant, Attorney, OIL, DOJ— U.S. Department of Justice, Civil Division/Office of Immigration Litigation, Washington, DC, Chief Counsel ICE, Office of the Chief Counsel, Department of Homeland Security, San Francisco, CA, for Respondent

Before: LEAVY, W. FLETCHER, and OWENS, Circuit Judges.

*

 The panel unanimously concludes this case is suitable for decision without oral argument. *See*Fed. R. App. P. 34(a)(2).

MEMORANDUM **

Cong Thanh Chau, a native and citizen of Vietnam, petitions pro se for review of the Board of Immigration Appeals’ order summarily affirming an immigration judge’s (“IJ”) order denying his motion to reconsider and reopen removal proceedings. Our jurisdiction is governed by 8 U.S.C. § 1252. We review for abuse of discretion the denial of a motion to reopen or reconsider and review de novo questions of law. *Mohammed v. Gonzales,*400 F.3d 785, 791-92 (9th Cir. 2005). We deny in part and dismiss in part the petition for review.

The agency did not abuse its discretion in denying Chau’s motion to reconsider and reopen as untimely, where it was filed fourteen years after his final order of removal, *see*8 C.F.R. § 1003.23(b)(1), and Chau failed to establish any exception to the filing deadline, *see*8 C.F.R. § 1003.23(b)(4).

To the extent Chau contends he is eligible for status under 8 U.S.C. § 1154(f), the IJ correctly noted that the granting of such status is outside of the immigration court’s jurisdiction, *see*8 U.S.C. § 1154(f)(1) (petition for classification is to be filed with the Attorney General), and the record does not reflect that Chau has filed such a petition.

To the extent Chau requests prosecuto-rial discretion, we lack jurisdiction to consider that request. *See Vilchiz-Soto v. Holder,*688 F.3d 642, 644 (9th Cir. 2012) (order).

Chau’s remaining contentions, including alleged violations of due process, equal protection, and international law, are unpersuasive.

PETITION FOR REVIEW DENIED in part; DISMISSED in part.

**

 This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3.